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Abstract
Dynamic extracellular matrix (ECM) synthesis is explored in a hypothesized engineered cartilage
construct. Growth (α) and decay (β) rate parameters are developed from a previous engineered
cartilage model. The presented mathematical model was constructed from the parameterized
experimental data using a deterministic and stochastic examination of ECM synthesis based on a
negative feedback control mechanism. A growth factor supplementation is incorporated in a
probabilistic mathematical approach. The growth factor component modified an initial deterministic
model through a Gaussian white noise fluctuation. As the primary constituents of ECM, the
mathematical tool is intended to characterize the probable steady state distribution of
glycosaminoglycan (GAG) and collagen molecules as well as mean mass accumulation at
homeostasis. Computer simulation of the models is applied to reported data from four similar
chondrocyte-polymer construct culture systems. The range in rate ratios reflect the differing nature
of GAG and collagen synthesis (αGAG/βGAG = 4.2 to 148.6; αcollagen/βcollagen = 8.1 to 2590.4). This
technique reduced the influencing synthesis factors to a few key descriptive parameters. Additional
anabolic and catabolic factors may further be built into the models.
Keywords
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Introduction
Functional characteristics of articular cartilage involve the response of active load bearing
(compressive and shear forces) within diarthrodial joints. Damage to the articulating surface
can occur due to adverse mechanical and biological perturbations. Despite being a living tissue
it has a limited capacity for healing. Damage to the articular surface may spread, resulting in
pain and loss of joint movement. With minimal regenerative potential, degenerative damage
can lead to osteoarthritis. This joint disease is the most common form of arthritis in Australia
where 5 to 10% of the total population is affected.1 In the United States, more than one million
people require treatment per year for damaged articular cartilage.2
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Native articular cartilage is a composite of cartilage cells (chondrocytes), extracellular matrix
(ECM), and water. The three main biomolecular components of ECM are structural proteins,
specialized proteins, and proteoglycans. Structural proteins consist of type II collagen and
elastin, specialized proteins consist of fibrillin, fibronectin, and laminin, and lastly,
proteoglycans are core proteins to which are attached long chains of repeating disaccharide
units known as glycosaminoglycans (GAG). The mechanical behaviour of cartilage is strongly
influenced by constituent content and the electrostatic forces between matrix charge groups.
3 Quantifying collagen and GAG content over time provides an indicator of the state of ECM
and the chondrocyte regenerative or degenerative potential.
Existing techniques to repair damaged articular cartilage with autograft/allograft transplants
have had limited success. Tissue engineered cartilage offers a possible alternative. Cartilage
tissue engineering typically utilizes the seeding of chondrogenic cells into biodegradable
polymeric scaffolds.4–8 In this arrangement, ECM concentration in cell-polymer constructs is
designed to gradually increase and form neo-tissue while scaffold concentration decreases with
time.9 However, the role of ECM in maintaining and modulating cell function is not fully
understood although recent reports have described the role of receptor molecules such as
integrins in regulating chondrocytes.10–11
A relatively strong negative correlation has been observed between GAG molecule deposition
within ECM and its synthesis rate in the study of native12 and engineered4 cartilage. This
result is consistent with that reported from in vitro modulation of chondrocyte metabolism by
extracellular proteoglycan.13 Based on this product inhibition mechanism, a mathematical
formulation for GAG deposition was described by Hascall et al.12,14 and adapted for use in
cartilage tissue engineering by Wilson et al.9 for a characterization of ECM mass or
concentration:
d(ECM )
dt = kECM{(ECM )SS − (ECM )} (1)
where kECM is an ECM synthesis rate constant and the steady-state (ss) condition occurs at t
→ ∞ and d(ECM)/dt = 0. Thus ECM mass or concentration as a function of time follows the
form:
(ECM )t = (ECM )SS 1 − e
−kECMt . (2)
Degradation of scaffold mass or concentration is also assumed to follow a first order decay
equation:9
d(scaffold)
dt = − kS(scaffold) (3)
where ks is the scaffold decay rate constant. Again, this implies at time-dependent
characterization as:
(scaffold)t = (scaffold)initiale
−kSt. (4)
By combining the mathematical formulations (2) and (4), along with the cellular mass content,
a total construct mass model is proposed and experimentally validated as a function of culture
time.9 In the above approach, dependencies between chondrocyte function and ECM molecule
production rates as well as the effect of local biomechanical or biochemical factors are not
explicitly taken into account.
Saha et al. Page 2
Australas Phys Eng Sci Med. Author manuscript; available in PMC 2006 March 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
It is well established that growth factors and cytokines modulate cell function and cartilage
development.15–18 The effects depend on specific combinations of factors, time sequences of
their application, and interactions with the mechanical environment (hydrodynamic shear and
compression). It has been observed experimentally by several investigators that growth factors
play an important role in matrix production and inhibition, but there is limited knowledge about
the functional mechanisms associated with these effects.16–22 This leads to the present
objective which is to explore the influence of growth factors within engineered cartilage by
modelling hypothetical characteristics of ECM synthesis.
In previous approaches, we presented predictive models which examined deterministic and
stochastic mechanisms of engineered cartilage composition. These works examined cellular
proliferation effects,23 a randomised influence of growth factors on synthesis rate,24 a
deterministic approach with exponential synthesis terms,25 and a randomised influence of
growth factors limited by a carrying capacity parameter with an initial growth factor state.25
Here, dynamic compositional models are again formulated albeit with concomitant growth and
decay rate terms. These modelling iterations investigate possible influences in the modulation
of ECM synthesis which could be manipulated to enhance the regenerative potential in cartilage
therapies. Therefore, the specific aims of this study are to: a) develop a deterministic
mathematical model based on published experimental results that describe the accumulation
of matrix molecules using distinct rate terms; b) quantify a ‘growth factor effect’ on matrix
molecule deposition through a stochastic influence on the synthesis rate term. Both of these
modelling approaches are based on current cell-polymer constructs developed for tissue
engineered cartilage.
Methods and materials
Deterministic control model
An alternative deterministic model is presented to describe the accumulation of ECM
molecules in a cell-polymer construct based on a negative feedback control mechanism. This
approach applies distinct growth and decay rate terms originally reported for GAG molecules.
4,13 Here, the model is introduced to describe ECM mass or concentration:
d(ECM )
dt =
α0
1 + (ECM ) − β0(ECM ) (5)
where α0 and β0 are, respectively, the natural growth and decay rates of ECM molecules in a
cell-polymer construct. The first term in equation (5) incorporates the feedback mechanism for
the system. During variable manipulation, ECM is replaced by X and restated as:
dX
dt =
α0
1 + X − β0X (6)
of which the general solution is:
(Z + Ω)
1
2 −Ω
(Z − Ω)
1
2 +Ω
= Ce2Ωβ0t (7)
where:
Z = X + 12 and Ω =
α0
β0
+ 14 . (8)
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At the initial condition, t = 0, when chondrocytes are seeded into a polymeric scaffold, the
ECM concentration is zero and:
C = 22Ω (1 + 2Ω)
1
2 −Ω
(1 − 2Ω)
1
2 +Ω
. (9)
In the steady state condition (t → ∞), Z → Ω and:
X → XSS = −
1
2 +
α0
β0
+ 14 (10)
By assuming that both GAG and collagen molecules follow the same growth kinetics within
ECM, the Deterministic Control Model describes steady state (ss) content:
GAGSScontrol = −
1
2 +
αGAG
βGAG
+ 14 (11)
where, αGAG and βGAG are the natural growth and decay rates, respectively, of GAG molecules
and:
collagenSScontrol = −
1
2 +
αcollagen
βcollagen
+ 14 (12)
where, αcollagen and βcollagen are the natural growth and decay rates, respectively, of collagen
molecules. By combining equations (11), (12), scaffold degradation of (4), and the cellular
mass content, MSScell, the mean mass of the total engineered cartilage construct, MSScontrol, in
the steady state can then be described:
MSScontrol = Msscell + ( − 12 + αGAGβGAG + 14 ) +( − 12 + αcollagenβcollagen + 14 ) + limt→∞(scaffold)initiale−kSt (13)
Stochastic growth hormone treated model
ECM molecule dynamics are further explored through the inclusion of hypothetical growth
factor effects. As the functional characteristics of the growth factors are not exactly known,
their influence is treated here as random fluctuations. This influence is incorporated into the
modelled system as Gaussian white noise. The presence of growth factor is assumed to
manipulate the growth rate constant such that:
d(ECM )
dt =
α0 + ρ0ξ(t)
1 + (ECM ) − β0(ECM ) (14)
where, ρ0ξ(t) is the time-dependent, randomised contribution to the synthesis rate. Equation
(14) can be rewritten as:
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d(ECM ) = { α01 + (ECM ) − β0(ECM )}dt +
ρ0
1 + (ECM ) ξ(t)dt
(15)
where the random noise function, ξ(t), has the following mean and covariance conditions:
E ξ(t) = 0
Cov ξ(t), ξ(s) = δ(t − s) (16)
A replacement term can be utilized, based on the interpretation of the integral of ξ(t) :26–27
dW (t) = W (t + dt) − W (t) = ξ(t)dt (17)
and dW (t) ~ N(0, dt)
where N(μ, σ) is a normal distribution with mean, μ, and standard deviation, σ. Equation (15)
then becomes:
d(ECM ) = { α01 + (ECM ) − β0(ECM )}dt +
ρ0
1 + (ECM ) dW (t)
(18)
The corresponding Fokker-Planck equation can be applied with the intent of describing the
probabilistic distribution of the matrix molecules:26–28
∂P(ECM, t)
∂t = −
∂
∂(ECM ){ α01 + (ECM ) − β0(ECM )}P(ECM, t) +
1
2
∂2
∂(ECM )2 { ρ01 + (ECM ) }2P(ECM, t)
(19)
where, P(ECM ,t) is the probability density function (PDF) of ECM deposition at time t. In the
steady state, as t → ∞ and d(ECM)/dt = 0, the PDF of P(ECM, ∞) or P∞(ECM) satisfies:
d 2
d(ECM )2 { ρ01 + (ECM ) }2P∞(ECM ) −
2 dd(ECM ) { α01 + (ECM ) − β0(ECM )}P∞(ECM ) = 0 (20)
Therefore, the steady state PDF of ECM deposition, Pss(ECM) , is proportional to:
(1 + ECM )2exp (ECM )
ρ02
{2α0 + (α0 − β0)(ECM ) −
4β0
3 (ECM )
2 −
β0
2 (ECM )
3} (21)
and thus,
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PSS(ECM ) = C0(1 + ECM )2
e
(ECM )
ρ02
{2α0+(α0−β0)(ECM )− 4β03 (ECM )2− β02 (ECM )3} (22)
where the constant of proportionality,C0, can be obtained by solving:
∫
−∞
+∞
PSS(ECM )d(ECM ) = 1 (23)
Thus, equation (22) represents the generalized PDF for the matrix molecules. The steady state
PDF for the primary ECM molecules are assumed to be independent of each other and
controlled by their own growth and decay rates.
Thus the PDF of GAG molecule deposition is given by:
P∞(GAG) = CGAG(1 + GAG)2
e
GAG
ρGAG2
{2αGAG+(αGAG−βGAG)(GAG)− 4βGAG3 (GAG)2− βGAG2 (GAG)3} (24)
and the PDF for collagen molecule deposition:
P∞(collagen) = Ccollagen(1 + collagen)2
e
collagen
ρcollagen2
{2αcollagen+(αcollagen−βcollagen)(collagen)− 4βcollagen3 (collagen)2− βcollagen2 (collagen)3} (25)
For the overall mass of the engineered construct, it is assumed that growth factor stimulation
and accumulated ECM have no effect on scaffold degradation. The scaffold concentration
follows a simple first order decay.9 It is also assumed that cellular mass, MSScell, reaches a
constant level after proliferating to a concentration level specific to the culture environment.
29 Here, this cellular concentration is assumed to be independent of the growth factor-
influenced ECM synthesis rates. The mean total engineered cartilage construct mass in the
steady state, MSStreated , can thus be described as:
MSStreated = MSScell + ∫
−∞
+∞
(GAG)P∞(GAG)d(GAG) +
∫
−∞
+∞
(collagen)P∞(collagen)d(collagen) + limt→∞
(scaffold)initiale
−kSt
(26)
where the integral terms define the ECM mass associated with mean distribution, P¯∞(ECM ).
Computational analysis
Application of the Deterministic Control Model and the Stochastic Treated Model require
quantified parameters which characterize engineered cartilage content. Reports of direct and
indirect assays for cell, ECM, and scaffold content through periods of culture are available for
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parameterization.9 In addition, the intrinsic synthesis rate, k, or one over the characteristic time
constant, τ, as defined in the initial model,9 is applied here as a second equation to determine
the two unknown rates of growth and decay for model input:
k = 1τ = α0 − β0 (27)
Thus, the steady state values of ECM molecules, GAGss and collagenss, as well as the
characteristic time constants which have been previously determined from experimental data
are incorporated into the presented models.9,29–31 Solutions from equations (11) and (12)
combined with relationship (27) defined the rate parameters for each biomolecule: αGAG,
βGAG, αcollagen, and βcollagen (Table 1). Representative experimentally derived characteristic
time constants and kinetic rates of scaffold degradation have been included for comparison
(Table 2). All variable manipulation and computational analysis were completed on
commercially available software (MathCAD v12, Mathsoft Engineering and Education, Inc.,
Cambridge, MA).
Results
The specific aims of this work were satisfied through t h e formulation and application of two
mathematical models characterizing ECM synthesis within generalized engineered cartilage
constructs. Previously parameterized data from four published reports were used to define the
growth and decay rates for application in the current models (Table 1). The computer
simulations using the Deterministic Control Model reflect the variety of GAG and collagen
accumulation growth patterns found in engineered cartilage studies (Figure 1). The curves
describe matrix molecule synthesis based on the numerical analysis of experimentally observed
engineered cartilage steady state values and intrinsic growth rates as input. The resulting curves
were not ‘fitted’ to the previous data but utilize parameters previously defined from that data.
The mathematical model was based on two input variables and therefore does not consider the
multitude of constituent interactions within ECM which may or may not account for differences
between constituents.
The Stochastic Growth Hormone Treated Model resulted in distribution frequencies of ECM
accumulation based on the PDF for each molecule. The randomised growth hormone affect on
synthesis rate again produced a variety of accumulation patterns (Figure 2). These distribution
patterns for each of the four studies describe probabilistic accumulation as influenced from a
single initial relative growth hormone level (ρGAG = ρcollagen = 2.0). Again, the model does
not account for a myriad of possible influences in accumulation which could be causing the
dramatic differences between GAG and collagen content. Finally, mean steady state
accumulations were compared between Control and Treated Models as simulated for both GAG
and collagen (Figure 3). Although the expected increase in accumulation due to a stimulated
growth rate is apparent, the diverse effect within the four sets of parameters is noticeable.
Discussion
In this work, generalized mathematical models of cartilage matrix molecule accumulation in
engineered cell-polymer constructs have been constructed based on parameters derived from
previous experimental results. The models incorporated a product inhibition mechanism via a
negative feedback control network where the rate of synthesis decreases during matrix
production.
The presented models provide an analytical tool from which to identify synthesis-influencing
variables and parametrically compare empirical data. A new technique is formulated to
explicitly determine growth and decay rates of matrix molecules at the steady state condition.
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In the deterministic model, these two rate parameters characterize the time-dependency of
growth leading to the steady state condition. The generalized mathematical model is further
studied in an environment where growth factors hypothetically influence the dynamics of
matrix molecule accumulation within the cell-polymer construct. The biophysical knowledge
of growth factors in cell-polymer constructs is generally insufficient for full analytical
prediction. Researchers are investigating the modulatory mechanisms of these growth factors
through computational33 and experimental34 efforts to define explicit physical laws. The
presented approach represents a modelling continuation which explores ECM synthesis
through deterministic descriptions and stochastic fluctuations within the system dynamics in
order to identify the action potentials of anabolic and catabolic factors within the engineered
constructs.23–25 In each of the previous models, published data describing ECM was used to
construct models which, in turn attempted to characterize the results based on: cellular
proliferation effects,23 deterministic steady state boundaries,25 and stochastic contributions
of growth factors on mathematical synthesis terms.24,25
The presented deterministic model is again built from parameters defined by cultured
experimental constructs. The stochastic modification proposes that the ‘growth factor effect’
acts only on the growth rates of the ECM molecules as distinguished from a decay rate. As a
basis for comparison with other growth factor studies, the model shows that an increase in the
relative level of growth factor will create more random fluctuations within the system and thus
the overall (mean) production of a matrix molecule will be higher. This result is similar to what
has been observed experimentally by several researchers describing anabolic manipulation.
10,18,35–37 These investigations reported on positive response in synthesis due to sequential
application of various factors. Specifically, recombinant osteogenic protein-1 (OP-1), also
known as bone morphogenetic protein-7 (BMP-7), stimulates ECM production. It has been
reported that type II collagen and proteoglycan synthesis increases in bovine and human
articular chondrocytes. It has also been reported that insulin-like growth factor (IGF-1) and
transforming growth factor (TGF-2) influence proteoglycan synthesis and accumulation in the
cell associated matrix.37 These growth factors increase the concentration of proteoglycans
although rate effects are not clear.
The models represent a new method to estimate the homeostasis of each matrix molecule
species within the construct through incorporation of growth and decay rates. As with any
model, limitations exist. Here interactions between molecules or between ECM and the scaffold
material are not explored. Although the parameterization process reduces the many possible
synthesis influencing factors or variables into a few terms, it does not provide the subtle
modification with known active or inactive states of ECM, growth factors, chrondrocytes, etc.
which comprise the overall composite. These additional influences may be the cause of the
variety of differences shown between GAG and collagen synthesis states (Figures 1 to 3). The
reduction of influencing terms and a clear mathematical model does, however, provide a
starting point for comparison between the various studies. Additionally, the functional nature
of the resulting constructs, although often analysed, are not incorporated into a mechanical
result here. Interactions between constituents and the mechanical implications are being
explored in ongoing modelling efforts.38
The models use a simplified approach to investigate matrix molecule biosynthesis under the
influence of growth factors. Model outcomes can be used to parametrically compare
experimental results as well as to explore matrix concentration in the steady state due to
additional anabolic and catabolic factors. As a predictive tool, the models may be able to assess
culture times necessary to produce a functionally viable construct. This potential application
will require a transient analysis of the proposed model, which is currently underway.
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Figure 1.
Simulated time-dependent ECM accumulation leading to steady state levels using the
Deterministic Control Model, equations (7) through (12). Input parameter values were chosen
from reported cartilage engineering experimental data (Table 1): a) Freed et al.29; b) Vunjak-
Novakovic et al.30; c) Wilson et al.9; and d) Vunjak-Novakovic et al.31.
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Figure 2.
Distribution plots produced from the Probability Density Function describing mean ECM
accumulation at the steady state condition for each of the modelled constituents, equations (24)
and (25). Here, the growth and density rates for both GAG and collagen were incorporated
from representative published cartilage engineering experiments (Table 1): a) Freed et al.29;
b) Vunjak – Novakovic et al.30; c) Wilson et al.9; and d) Vunjak - Novakovic et al.31. For all
distributions, the relative growth factor effect is the same, ρGAG = ρcollagen = 2.0.
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Figure 3.
A comparison of the mean steady state ECM accumulation with supplemented growth factor
effects. Steady state values of growth factor-influenced accumulation are calculated from the
means of the probability functions, P¯∞(ECM ), applied to equations (24) and (25) and shown
for each constituent in equation (26). ECM growth and density rates were incorporated from
representative published cartilage engineering experiments (Table 1): A) Freed et al.29; B)
Vunjak-Novakovic et al.30; C) Wilson et al.9; and D) Vunjak-Novakovic et al.31. For each
ECM constituent, mean accumulation values are determined at distinct relative growth factor
levels within the Stochastic Treated Model, ρGAG = ρcollagen = 0.3, 0.5, 0.8, 1.0, and 2.0.
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Accumulation at ρ0 = 0 represents the mean steady state level from the Deterministic Control
Model.
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